Clinical application of ultrasonic debridement in the treatment of periprosthetic infection

Clinical application of low frequency ultrasound debridement in the treatment of periprosthetic infection

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063454

Enrollment

Unknown

Registered

2022-09-07

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periprosthetic infection after total hip and knee arthroplasty

Interventions

Experimental group:Low frequency ultrasonic debridement

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing total hip and knee revision arthroplasty or DAIR; 2. Aged 18-80 years; 3. The patient signs the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Patients with systemic infection symptoms such as sepsis; 2. Allergic constitution; 3. Infectious arthritis; 4. Patients who cannot tolerate surgery; 5. Patients participating in other clinical trials; 6. Pregnant or lactating women; 7. The researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

Measure	Time frame
Reinfection rate;	—

Secondary

Measure	Time frame
fuctional score;	—

Countries

China

Contacts

Public ContactCao Li

The First Affiliated Hospital of Xinjiang Medical University

xjbone@sina.com+86 13909915960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026